Financials
- Financial year
- 2026
- Total assets
- €258,837
- Profit
- €13,207
- Solvency
- 26.6%
Total assets▼ 11.7%
Net result
20192026
APOTHEEK CORNELUS
ActiveSummary
APOTHEEK CORNELUS has been active since 2004 and the Belgian Official Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €68,904 and a net result of €13,207. Equity is growing by about 10% per year across the filed financial years. Its solvency ranks better than 40% of 465 sector peers (NACE 47, financial year 2026). The computed 12-month bankruptcy probability is 0.4% (very low).
Overview
Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€258,837total assets 2026
- Equity
- €68,904
- Profit
- €13,207
Turnover not published (micro format)
Structure
2026 accounts 118 days early
Why 85raises riskSector: Retail trade (NACE 47)Liquidity: current ratio 2.53, cash €6,305, halvedlowers riskFounded in 2004Figures for financial year 2026 (filed 05-10-2026)Show the evidence
Checked score
Score 2026
85
/ 100
Excellent
Probability in this band: under 0.55%
Financially better than 55% of its sector peers (NACE 47, micro)
Financial strength · tick = 2025
Average
Solvency
52+8
equity 26.6% of total assets
Liquidity
44+26
short-term debt 25.3% · cash 2.4%
Profitability
75+2
return on assets 5.1%
Bankruptcy probability, 12 months
0.4%
Very low
0%0.5%1.5%4%10%≥ 25%
About 4 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: 0.2%
12-2024: 0.2%● unchanged vs 11-2024
01-2025: 0.4%▲ +0.2 percentage points vs 12-2024highest value
02-2025: 0.2%▼ -0.2 percentage points vs 01-2025
03-2025: 0.2%● unchanged vs 02-2025
04-2025: 0.2%● unchanged vs 03-2025
05-2025: 0.2%● unchanged vs 04-2025
06-2025: 0.2%● unchanged vs 05-2025
07-2025: 0.2%● unchanged vs 06-2025lowest value
08-2025: 0.2%● unchanged vs 07-2025lowest value
09-2025: 0.2%● unchanged vs 08-2025lowest value
10-2025: 0.2%● unchanged vs 09-2025
11-2025: 0.2%● unchanged vs 10-2025
12-2025: 0.2%● unchanged vs 11-2025
01-2026: 0.4%▲ +0.2 percentage points vs 12-2025
02-2026: 0.3%▼ -0.1 percentage points vs 01-2026
03-2026: 0.3%● unchanged vs 02-2026
04-2026: 0.3%● unchanged vs 03-2026
05-2026: 0.3%● unchanged vs 04-2026
06-2026: 0.3%● unchanged vs 05-2026
07-2026: 0.3%● unchanged vs 06-2026
08-2026: 0.3%● unchanged vs 07-2026
09-2026: 0.3%● unchanged vs 08-2026
10-2026: 0.4%▲ +0.1 percentage points vs 09-2026
Credit of up to €5,000 on 30-day terms is acceptable
Liquidity ample (current ratio 2.53, compared with 0.77 in 2025, above the usual 1.5; short-term debt: 25.3% and cash: 2.4% of total assets), but 73.4% of the assets are financed with debt and provisions.
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 42% on solvency, 42% on liquidity, 62% on profitability and 76% on growth.
The bankruptcy probability was computed on 25-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2026 was due by 31-01-2027 and was filed on 05-10-2026, 118 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2026
118 days early
2025
19 days early
2024
15 days early
2023
41 days early
2022
40 days early
2021
5 days early
2020
62 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 43 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 30-06-2027 and is due by 31-01-2028. Nothing is late today. The company usually files around 22 December (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsWhere today falls in the filing period
26-10-2026 today30-06-2027 year end31-01-2028 deadline
- Annual accounts filedfinancial year 2026 · micro…
- Liquidity more than triplescurrent ratio 2.53
- Annual accounts filedfinancial year 2025 · micro…
Key points
By topic
Timeline
- Events
- 28
- Since
- 2006
- Next accounts
- by 31-01-2028
- 30-06-2025Weakest financial year
- 16-01-2025Annual accounts filed
- 21-12-2023Annual accounts filed
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Founded
- 15-01-2004
- Year ends
- 30-06
- Peppol
- Reachable for e-invoices
Articles of association
- Provisions read
- 30
- Annual meeting
- Third Wednesday of December at 19:00
- Purpose
- “1.Hetadministratiefencommercieelbeheervanéénofmeerapothekenuitgebaatonderhetwetenschappeli…” (deed in Dutch)
Key facts about APOTHEEK CORNELUS
- What is the company number of APOTHEEK CORNELUS?
- 0862.682.663. In Belgium the VAT number is the company number with BE in front: BE 0862.682.663.
- Where is APOTHEEK CORNELUS based?
- The registered office is at Lekedorpstraat(L) 17, 8600 Diksmuide.Company details
- What does APOTHEEK CORNELUS do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of APOTHEEK CORNELUS?
- Private limited company (BV).
- When was APOTHEEK CORNELUS founded?
- On 15-01-2004.
- Is APOTHEEK CORNELUS still active?
- Yes, APOTHEEK CORNELUS is an active enterprise in the KBO register.
- How many employees does APOTHEEK CORNELUS have?
- On average 0.1 full-time equivalents in financial year 2020, according to the filed annual accounts.Financials
- What is the turnover of APOTHEEK CORNELUS?
- Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
- Is APOTHEEK CORNELUS profitable?
- In financial year 2026, APOTHEEK CORNELUS made a profit of €13,207.
- Where can I find the annual accounts of APOTHEEK CORNELUS?
- APOTHEEK CORNELUS filed 22 annual accounts with the National Bank of Belgium, the latest for financial year 2026.
- When are the next annual accounts of APOTHEEK CORNELUS due?
- By 31-01-2028, for financial year 2027.Timeline
Companies related to APOTHEEK CORNELUS
Comparable companies
- LONDON PHARMAElsene
- Apotheek De SwaeneBrugge
- PHARMACIE FREDERICJette
- Pharmacie des CroisadesSchaarbeek
- RiethPharmaMortsel
Go further with this company
How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.